Nanning Jirui Biopharmaceutical

Nanning Jirui Biopharmaceutical is a high-tech biotechnology company based in Nanning, China, specializing in the development and manufacturing of recombinant proteins and antibody drugs. The company operates a proprietary high-efficiency mammalian cell expression platform designed to accelerate the production of complex biologics for research and clinical applications. Their business model encompasses both internal drug discovery programs and Contract Development and Manufacturing Organization (CDMO) services, providing high-quality raw materials and technical support to the global life sciences industry. Nanning Jirui focuses on therapeutic areas such as oncology and infectious diseases, leveraging advanced bioprocessing technologies to improve yield and stability of biological products.